# Anika Therapeutics, Inc.: filings

ANIK · Nasdaq · CIK 898437 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/anik.md) · [Financials](/companies/anik/financials.md) · [Filings](/companies/anik/filings.md) · [Insiders](/companies/anik/insiders.md)

## Reports and events: 267 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 335, 8-K 163, SC 13G/A 68, 10-Q 53, 3 28, DEFA14A 25, DEF 14A 19, 10-K 18, SC 13G 16, S-8 15, SCHEDULE 13G/A 8, 8-K/A 4, ARS 4, UPLOAD 4, SC 13D/A 3, 10-K/A 2, 10-Q/A 2, CORRESP 2, DEFR14A 2, PRE 14A 2, PREC14A 2, PRER14A 2, SCHEDULE 13D/A 2, SCHEDULE 13G 2, SEC STAFF LETTER 2, 144 1, 3/A 1, 4/A 1, CT ORDER 1, DFAN14A 1, PRRN14A 1, S-8 POS 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-07-29 | 16:09 ET | [10-Q](/filings/0001171843-26-005012.md) | Quarterly report, period 2026-06-30 | 0001171843-26-005012 |
| 2026-07-29 | 07:20 ET | [8-K](/filings/0001171843-26-004977.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-004977 |
| 2026-07-14 | 17:00 ET | [8-K](/filings/0001171843-26-004635.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001171843-26-004635 |
| 2026-06-23 | 16:05 ET | [8-K](/filings/0001171843-26-004253.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001171843-26-004253 |
| 2026-04-30 | 19:47 ET | [10-Q](/filings/0001171843-26-002852.md) | Quarterly report, period 2026-03-31 | 0001171843-26-002852 |
| 2026-04-29 | 07:20 ET | [8-K](/filings/0001171843-26-002799.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001171843-26-002799 |
| 2026-04-28 | 16:47 ET | [DEF 14A](/filings/0001140361-26-017488.md) | Proxy statement, period 2026-06-18 | 0001140361-26-017488 |
| 2026-03-03 | 18:49 ET | [10-K](/filings/0001171843-26-001275.md) | Annual report, period 2025-12-31 | 0001171843-26-001275 |
| 2026-02-26 | 07:18 ET | [8-K](/filings/0001193125-26-073401.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-073401 |
| 2026-01-27 | 19:29 ET | [SCHEDULE 13D/A](/filings/0000902664-26-000511.md) | Ownership report, active investor, amended | 0000902664-26-000511 |
| 2026-01-08 | 16:02 ET | [8-K](/filings/0001193125-26-007655.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-007655 |
| 2025-11-21 | 09:21 ET | [SCHEDULE 13D/A](/filings/0000902664-25-005133.md) | Ownership report, active investor, amended | 0000902664-25-005133 |
| 2025-11-05 | 16:01 ET | [10-Q](/filings/0001171843-25-007032.md) | Quarterly report, period 2025-09-30 | 0001171843-25-007032 |
| 2025-11-05 | 07:20 ET | [8-K](/filings/0001171843-25-007003.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-007003 |
| 2025-07-30 | 16:12 ET | [10-Q](/filings/0001171843-25-004826.md) | Quarterly report, period 2025-06-30 | 0001171843-25-004826 |
| 2025-07-30 | 07:21 ET | [8-K](/filings/0001171843-25-004810.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-004810 |
| 2025-07-30 | 07:15 ET | [8-K](/filings/0001171843-25-004809.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-004809 |
| 2025-06-24 | 17:01 ET | [8-K](/filings/0001171843-25-004062.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001171843-25-004062 |
| 2025-05-09 | 14:30 ET | [10-Q](/filings/0001171843-25-003019.md) | Quarterly report, period 2025-03-31 | 0001171843-25-003019 |
| 2025-05-09 | 07:20 ET | [8-K](/filings/0001171843-25-003005.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-003005 |
| 2025-04-28 | 17:26 ET | [DEF 14A](/filings/0001140361-25-016082.md) | Proxy statement, period 2025-06-20 | 0001140361-25-016082 |
| 2025-04-10 | 16:06 ET | [8-K](/filings/0001171843-25-002148.md) | 5.02 Departure or appointment of officers or directors | 0001171843-25-002148 |
| 2025-03-17 | 18:33 ET | [10-K](/filings/0001171843-25-001486.md) | Annual report, period 2024-12-31 | 0001171843-25-001486 |
| 2025-03-12 | 16:10 ET | [8-K](/filings/0001171843-25-001437.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-001437 |
| 2025-03-11 | 08:00 ET | [8-K](/filings/0001171843-25-001388.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-001388 |
| 2024-11-04 | 16:41 ET | [10-Q](/filings/0001171843-24-005993.md) | Quarterly report, period 2024-09-30 | 0001171843-24-005993 |
| 2024-10-31 | 07:20 ET | [8-K](/filings/0001171843-24-005923.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-005923 |
| 2024-10-31 | 07:16 ET | [8-K](/filings/0001171843-24-005922.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-24-005922 |
| 2024-08-08 | 17:21 ET | [10-Q](/filings/0001171843-24-004615.md) | Quarterly report, period 2024-06-30 | 0001171843-24-004615 |
| 2024-08-08 | 16:10 ET | [8-K](/filings/0001171843-24-004607.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-004607 |
| 2024-07-11 | 16:15 ET | [8-K](/filings/0001171843-24-003900.md) | 5.07 Shareholder vote results | 0001171843-24-003900 |
| 2024-06-11 | 17:05 ET | [DEF 14A](/filings/0001193125-24-159219.md) | Proxy statement, period 2024-07-09 | 0001193125-24-159219 |
| 2024-05-30 | 16:31 ET | [SC 13D/A](/filings/0000902664-24-003936.md) | Ownership report, active investor, amended | 0000902664-24-003936 |
| 2024-05-28 | 17:04 ET | [8-K](/filings/0001171843-24-003136.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-24-003136 |
| 2024-05-08 | 17:15 ET | [10-Q](/filings/0001171843-24-002682.md) | Quarterly report, period 2024-03-31 | 0001171843-24-002682 |
| 2024-05-08 | 16:12 ET | [8-K](/filings/0001171843-24-002673.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001171843-24-002673 |
| 2024-05-08 | 16:10 ET | [8-K](/filings/0001171843-24-002672.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-002672 |
| 2024-04-26 | 08:48 ET | [10-K/A](/filings/0001171843-24-002274.md) | Annual report, amended, period 2023-12-31 | 0001171843-24-002274 |
| 2024-03-15 | 12:20 ET | [10-K](/filings/0001171843-24-001380.md) | Annual report, period 2023-12-31 | 0001171843-24-001380 |
| 2024-03-13 | 16:10 ET | [8-K](/filings/0001171843-24-001322.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-001322 |
| 2024-03-06 | 19:30 ET | [SC 13D/A](/filings/0000902664-24-002242.md) | Ownership report, active investor, amended | 0000902664-24-002242 |
| 2024-02-26 | 09:00 ET | [8-K](/filings/0001171843-24-000972.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001171843-24-000972 |
| 2023-11-03 | 17:41 ET | [10-Q](/filings/0001171843-23-006687.md) | Quarterly report, period 2023-09-30 | 0001171843-23-006687 |
| 2023-11-02 | 16:11 ET | [8-K](/filings/0001171843-23-006678.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-23-006678 |
| 2023-09-21 | 07:55 ET | [8-K](/filings/0001171843-23-005813.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-23-005813 |
| 2023-09-11 | 06:01 ET | [SC 13D/A](/filings/0000902664-23-004717.md) | Ownership report, active investor, amended | 0000902664-23-004717 |
| 2023-08-17 | 08:00 ET | [SC 13D](/filings/0000902664-23-004496.md) | Ownership report, active investor | 0000902664-23-004496 |
| 2023-08-08 | 17:15 ET | [10-Q](/filings/0001171843-23-005114.md) | Quarterly report, period 2023-06-30 | 0001171843-23-005114 |
| 2023-08-08 | 16:11 ET | [8-K](/filings/0001171843-23-005107.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-23-005107 |
| 2023-06-21 | 16:50 ET | [8-K](/filings/0001171843-23-004058.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001171843-23-004058 |

Page 1 of 6. [Older](/companies/anik/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.